Search research articles
Contact Us
Filters
Showing results (371-380 of 395) with videos related to
Page
of 40
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2013
Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831
Amylou C Dueck, Monica M Reinholz, Xochiquetzal J Geiger, et al.
Plos One
|
May 1, 2015
Correction: Folate receptor-α (FOLR1) expression and function in triple negative tumors
Brian M Necela, Jennifer A Crozier, Cathy A Andorfer, et al.
Psychological Science
|
May 22, 2025
What We Think Others Think and Do About Climate Change: A Multicountry Test of Pluralistic Ignorance and Public-Consensus Messaging
Sandra J Geiger, Jana K Köhler, Zenith N C Delabrida, et al.
Cancers
|
February 11, 2023
One-Stage Synovectomies Result in Improved Short-Term Outcomes Compared to Two-Stage Synovectomies of Diffuse-Type Tenosynovial Giant Cell Tumor (D-TGCT) of the Knee: A Multicenter, Retrospective, Cohort Study
Geert Spierenburg, Floortje G M Verspoor, Jay S Wunder, et al.
Clinical Orthopaedics and Related Research
|
May 18, 2022
What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study Report
Erik J Geiger, Wei Liu, Deo Kumar Srivastava, et al.
Plos One
|
March 28, 2015
Folate receptor-α (FOLR1) expression and function in triple negative tumors
Brian M Necela, Jennifer A Crozier, Cathy A Andorfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2015
Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial
Edith A Perez, E Aubrey Thompson, Karla V Ballman, et al.
NPJ Breast Cancer
|
February 13, 2020
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients
Nadine Norton, Bahaaeldin Youssef, David W Hillman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2011
C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial
Edith A Perez, Robert B Jenkins, Amylou C Dueck, et al.
Translational Psychiatry
|
February 6, 2019
Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes
Michael G Gottschalk, Jan Richter, Christiane Ziegler, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 395) with videos related to
Sort By:
Page
of 40
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2013
Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831
Amylou C Dueck, Monica M Reinholz, Xochiquetzal J Geiger, et al.
Plos One
|
May 1, 2015
Correction: Folate receptor-α (FOLR1) expression and function in triple negative tumors
Brian M Necela, Jennifer A Crozier, Cathy A Andorfer, et al.
Psychological Science
|
May 22, 2025
What We Think Others Think and Do About Climate Change: A Multicountry Test of Pluralistic Ignorance and Public-Consensus Messaging
Sandra J Geiger, Jana K Köhler, Zenith N C Delabrida, et al.
Cancers
|
February 11, 2023
One-Stage Synovectomies Result in Improved Short-Term Outcomes Compared to Two-Stage Synovectomies of Diffuse-Type Tenosynovial Giant Cell Tumor (D-TGCT) of the Knee: A Multicenter, Retrospective, Cohort Study
Geert Spierenburg, Floortje G M Verspoor, Jay S Wunder, et al.
Clinical Orthopaedics and Related Research
|
May 18, 2022
What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study Report
Erik J Geiger, Wei Liu, Deo Kumar Srivastava, et al.
Plos One
|
March 28, 2015
Folate receptor-α (FOLR1) expression and function in triple negative tumors
Brian M Necela, Jennifer A Crozier, Cathy A Andorfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2015
Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial
Edith A Perez, E Aubrey Thompson, Karla V Ballman, et al.
NPJ Breast Cancer
|
February 13, 2020
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients
Nadine Norton, Bahaaeldin Youssef, David W Hillman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2011
C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial
Edith A Perez, Robert B Jenkins, Amylou C Dueck, et al.
Translational Psychiatry
|
February 6, 2019
Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes
Michael G Gottschalk, Jan Richter, Christiane Ziegler, et al.
Page
of 40